heamtological
disease |
Hb (g/dl) |
serum ferritin
(μg/ml) |
PLT ccount/mm3 |
ATIIIc |
PS freec |
PCc |
aPTT c |
D-dimer
(μg/ml) |
HSa
DVTb |
8.5 |
8.2 |
650.000 |
58 % |
50 % |
58 % |
45’’ |
>0.5 |
PK deficia
DVTb
CVTb |
7.5
7.2 |
8.5
8.2 |
600.000
620.000 |
44 %
50 % |
52 %
50 % |
56.2 %
55 % |
42’’
39’’ |
>0.5
>0.5 |
cITPa
DVTb |
8.2 |
7.2 |
620.000 |
50 % |
48 % |
50 % |
40’’ |
>0.5 |
CDIIa
CVTb |
9 |
200 |
750.000 |
45 % |
45 % |
53 % |
45’’ |
>0.5 |
TIa
CVTb |
9.2 |
480 |
780.000 |
42 % |
40 % |
49 % |
45’’ |
>0.5 |
a Hereditary Spherocytosis: HS; Piruvate Kynase Deficit: PK; Congenital Dyserithropoiesis II: CDII; Chronic Idiopathic Thrombocytopenic Purpura: cITP; β thalassemia
intermedia: TI
b DVT: Deep Venous Thrombosis; CVT: Cerebrovascular Thrombosis
c Activated Partial Thromboplastin Time: aPTT; Free Protein C activity: PC; Protein S: PS; Antithrombin III: AT III; Platelet count: PLT
|
